Jonathan Young - Chief Operating Officer at Akero Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Operating Officer
Stock Symbol
AKRO on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Jonathan Young - trading volume in the past year for Akero Therapeutics, Inc.

Holdings reported by Jonathan Young for Akero Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stoek 263K $6.59M $25.03 Apr 1, 2024 Direct
Common Stock 236K $6.19M $26.18 Sep 10, 2024 Direct
Common Stock 20K $524K $26.18 Sep 13, 2024 By CM Irrevocable Trust
Common Stock 20K $524K $26.18 Sep 13, 2024 By EA Irrevocable Trust
Common Stock 20K $524K $26.18 Sep 13, 2024 By JL Irrevocable Trust
Stock Option (Right to Buy) 0 Mar 1, 2024 Direct Common Stock

Transactions reported by Jonathan Young for Akero Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.